Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.8501
Nov 20 • 3:59 PM ET Dollar change-0.0743 Percentage change(-8.04%)
Aftermarket Close
0.8671
Aftermarket • 7:30 PM ET Dollar change+0.0170 Percentage change(2.00%)
Index
-
Market Cap
18.90M
Enterprise Value
7.78M
Income
-27.19M
Sales
160.26M
Book/sh
0.76
Cash/sh
0.51
Employees
189
IPO
Apr 26, 1999
P/E
-
Forward P/E
-
PEG
-
P/S
0.12
P/B
1.12
P/C
1.65
P/FCF
-
EV/EBITDA
-
EV/Sales
0.05
Quick Ratio
0.45
Current Ratio
0.60
Debt/Eq
0.02
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-1.28
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
-11.31% -10.35%
EPS Y/Y TTM
51.57%
Sales Y/Y TTM
-17.81%
EPS Q/Q
25.15%
Sales Q/Q
-19.37%
Insider Own
33.61%
Insider Trans
0.34%
Inst Own
21.16%
Inst Trans
0.11%
ROA
-34.05%
ROE
-90.76%
ROIC
-161.27%
Gross Margin
22.08%
Oper. Margin
-17.98%
Profit Margin
-16.97%
SMA20
-22.46%
SMA50
-32.86%
SMA200
-56.40%
Trades
Shs Outstand
22.13M
Shs Float
14.76M
52W High
4.10 -79.27%
52W Low
0.85 0.01%
Volatility
7.86% 6.36%
ATR (14)
0.07
RSI (14)
20.57
Beta
0.90
Rel Volume
0.99
Avg Volume
116.50K
Volume
115,757
Perf Week
-9.58%
Perf Month
-27.96%
Perf Quarter
-51.42%
Perf Half Y
-59.90%
Perf YTD
-73.43%
Perf Year
-47.03%
Perf 3Y
-88.99%
Perf 5Y
-97.11%
Perf 10Y
-96.13%
Prev Close
0.92
Price
0.85
Change %
-8.04%
Consensus
Strong Sell
Avg. Price Target
$1.40
Implied Upside
+64.7%
Analysts9incl. previous ratings
Rating Distribution4 Buy · 3 Hold · 2 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 25, 2023Initiated
LLake Street
Buy$20+2,252.7%
Jan 20, 2022Upgrade
SSidoti
Neutral → Buy$32+3,664.3%
Nov 18, 2021Initiated
MS logoMMorgan Stanley
Underweight$25+2,840.8%
Oct 01, 2021Initiated
JEF logoJJefferies
Hold$28+3,193.7%
Aug 05, 2021Resumed
CCredit Suisse
Underperform$22+2,487.9%
Jun 03, 2021Downgrade
SSidoti
Buy → Neutral$39+4,487.7%
Mar 05, 2021Upgrade
SSidoti
Neutral → Buy
Jan 27, 2021Downgrade
SSidoti
Buy → Neutral
Aug 19, 2020Upgrade
SSidoti
Neutral → Buy$37 → $41+4,723.0%
Apr 09, 2020Downgrade
SSidoti
Buy → Neutral
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NINA CAPITAL HOLDINGS INC.10% OwnerJun 08 '26Buy1.7525,00043,7252,600,000Jun 09 05:06 PM
PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs, cats, and horses. The firm provides treatments for allergies, arthritis, anxiety, dermatitis, diabetes, and heartworms. It offers access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Chief Accounting OfficerMr. Douglas Krulik